Heart patients to test app-based care for better blood pressure and cholesterol control

NCT ID NCT07332494

Not yet recruiting Disease control Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a smartphone app can help people with coronary heart disease better manage their blood pressure and cholesterol after having a stent placed. About 792 participants will either use the app for one year or receive usual care. The app reminds patients to check their blood pressure, tracks lab results, and suggests medication changes with doctor approval, aiming to improve heart health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: smartphone-based digital remote management platform
What this could lead to: If successful, this could provide an effective way for heart patients to manage their blood pressure and cholesterol at home, reducing the risk of future heart problems.
What could go wrong: This is an early-stage trial testing a new approach, so it may not prove better than standard care. Patients need to be comfortable using a smartphone app, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY HEART DISEASE PERCUTANEOUS CORONARY INTERVENTION

Contacts and locations

Locations

13810720787

Beijing, China
Beijing Tongren Hospital, Capital Medical University, Beijing, China

Beijing, China
The First Affiliated Hospital of Dalian Medical University, Dalian, China

Dalian, China
The First Hospital of Jilin University, Changchun, China

Jilin City, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.